Company news
Tristel PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Additional Investor Presentation
October 12, 2023
Health Canada regulatory approval submission
September 4, 2023
Shareholder Open Day and Notice of Trading Update
July 12, 2023
Analyst and Investor presentation
June 5, 2023
FDA De Novo approval
June 5, 2023
Issue of Equity
March 28, 2023
Successful submission of additional data to US FDA
March 27, 2023
Second Price Monitoring Extn
March 14, 2023
Price Monitoring Extension
March 14, 2023
Notice of Results and Investor presentation
January 30, 2023
Result of AGM - Replacement
December 14, 2022
Appointment of new Company Secretary
October 4, 2022
Notice of Results & Investor Presentation
October 4, 2022
North America update
September 29, 2022
Trading update and special dividend
July 18, 2022
De Novo FDA submission for Tristel Duo ULT
June 30, 2022
Shareholder Open Day & Notice of Trading update
June 20, 2022
Investor Presentation
May 4, 2022
Interim dividend confirmation
February 23, 2022
AGM Statement and notice of results
December 13, 2021
TR1: Notification of Major Holdings
July 29, 2021
Regulatory approval for EPA, Canada & South Korea
June 24, 2021
Total Voting Rights
April 1, 2021
Director/PDMR Shareholding and Issue of Equity
March 1, 2021
Notice of investor presentation
February 18, 2021
Exercise of Options
January 14, 2021
Director Appointment
December 24, 2020
Update to Executive Performance Share Plan 2021
December 2, 2020
Tristel wins AIM Growth Business of the Year Award
December 2, 2020
Q&A update following preliminary results
November 2, 2020
Dividend Timetable
October 19, 2020
Tristel's Duo for Ultrasound approved in India
August 21, 2020
Update from Virtual Shareholder Open Day
August 6, 2020
Notice of Trading update, Results & presentation
June 23, 2020
License & Product Supply Agreement with Byotrol
March 23, 2020
Director/PDMR Shareholding (Replacement)
February 25, 2020
Investor results presentation
January 15, 2020
Forthcoming Appointment of Non-Executive Chairman
November 26, 2019
Update on MobileODT strategic investment
November 18, 2019
Audited accounts and notice of AGM
November 1, 2019
Trading update, Acquisition & Notice of Results
July 22, 2019
Shareholder Open Day
June 5, 2019
Regulatory approvals in China and South Korea
April 1, 2019
Issue of Equity and PDMR Dealing
March 4, 2019
Acquisition & Board Appointment
November 19, 2018
Call the shots with Tristel's new surface disinfectant innovation
October 30, 2018
Result of secondary placing
July 16, 2018
Trading update & Notice of results
July 13, 2018
Issue of Equity
June 12, 2018
Director/PDMR Shareholdings
June 1, 2018
Calls
The 5 newest of 14 calls. Every call is listed under its year.
- Tristel (LSE:TSTL) Q4 2026 Earnings Call
Oct 19, 2026
Transcript - Tristel (LSE:TSTL) — Preliminary Results
Oct 19, 2026
Transcript - Tristel (LSE:TSTL) Q2 2026 Earnings Call
Mar 2, 2026
Transcript - Tristel (LSE:TSTL) — Interim Results
Mar 2, 2026
Transcript - Tristel (LSE:TSTL) — Preliminary Results for the year ended 30 June 2025
Oct 13, 2025
Transcript
Decks
The 5 newest of 22 decks. Every deck is listed under its year.
- ShareSoc Leeds (April 2026)
Conference · 26 slides · April 2026
- FY2025 Earnings Presentation
Earnings · 49 slides · October 2025
- Investor Presentation (June 2025)
Investor deck · 15 slides · June 2025
- Q2 2025 Earnings Presentation
Earnings · 31 slides · Feb 24, 2025
- Investor Presentation (October 2024)
Investor deck · 28 slides · October 2024